Artemisinin is generally considered safe when used in recommended doses for treating malaria. Clinical studies have shown it to have a relatively low toxicity profile. However, there are concerns about its neurotoxicity, particularly with high doses or prolonged use. Animal studies have shown evidence of neurotoxicity, such as damage to certain brain regions, but these effects have not been consistently observed in humans at therapeutic doses.
